Zeng Huiqiong, Zhou Kaixia, Ye Zhizhong
Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, Guangdong 518040, P.R. China.
School of Biomedical Sciences, CUHK-GIBH CAS Joint Laboratory on Stem Cell and Regenerative Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, SAR, P.R. China.
Exp Ther Med. 2022 Jun 7;24(2):495. doi: 10.3892/etm.2022.11422. eCollection 2022 Aug.
Autoimmune diseases (AIDs) are characterized by dysfunction and tissue destruction, and recent studies have shown that interleukin (IL)-37 expression is dysregulated in AIDs. Among cytokines of the IL-1 family, most are pro-inflammatory agents, and as an anti-inflammatory cytokine, IL-37 may have the potential to alleviate excessive inflammation and can be used as a ligand or transcription factor that is involved in regulating innate and adaptive immunity. IL-37 plays important roles in the development of AIDs. This review summarizes the biological characteristics and functions of IL-37 and discusses the potential of IL-37 as a therapeutic target for effective cytokine therapy and as a biomarker in AIDs.
自身免疫性疾病(AIDs)的特征是功能障碍和组织破坏,最近的研究表明,白细胞介素(IL)-37在AIDs中的表达失调。在IL-1家族的细胞因子中,大多数是促炎因子,而作为一种抗炎细胞因子,IL-37可能具有减轻过度炎症的潜力,并且可以用作参与调节先天性和适应性免疫的配体或转录因子。IL-37在AIDs的发展中起重要作用。本文综述了IL-37的生物学特性和功能,并讨论了IL-37作为有效细胞因子治疗的治疗靶点以及作为AIDs生物标志物的潜力。